Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOFERSEN vs TOLVAPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TOFERSEN vs TOLVAPTAN: Safety Overview

Metric TOFERSEN TOLVAPTAN
Total FAERS Reports 366 9,014
Deaths Reported 60 1,709
Death Rate 16.4% 19.0%
Hospitalizations 97 2,467
Average Patient Age 56.9 yrs 56.2 yrs
% Female Patients 48.3% 52.0%
FDA Approval Date Apr 25, 2023 Apr 23, 2018
Manufacturer Biogen Inc. Otsuka America Pharmaceutical, Inc.
Route INTRATHECAL ORAL
Marketing Status Prescription Prescription